FindTrial
Sign In

Role of steroids in IgA nephropathy and correlation with Oxford MEST Classification

A longitudinal observational study of clinical spectrum of IgA nephropathy and its co-relation to histopathology and outcome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/02/007768
Enrollment
30
Registered
2017-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N08- Glomerular disorders in diseases classified elsewhere Health Condition 2: null- Primary Immunoglobulin A Nephropathy

Interventions

None listed

Sponsors

Department of NephrologyIPGMER Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Primary IgA nephropathy on kidney biopsy.

Exclusion criteria

Exclusion criteria: 1)Patients with secondary IgA Nephropathy. 2)Patients with Henoch Schonlein Purpura ( HSP ) 3)Patients with concomitant diseases that affect the progression of kidney disease. 4)Patients not giving consent or unwilling to participate in the study. 5)Pregnant patients

Design outcomes

Primary

MeasureTime frame
Complete clinical remission, Complete Protienuria remission, Partial Proteinuria remission, End Stage Renal Disease, Death due to any cause. Timepoint: 3 monthly intervals till the end of study—

Secondary

MeasureTime frame
50% or more decline of eGFRTimepoint: 3 monthly intervals—

Countries

India

Contacts

Public ContactSmita S Divyaveer

IPGMER KOLKATA

rajensankrityan@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026